BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

  November 6, 2025

   · 

  4 min read
• Press Releases

  Quebec Expands Public Funding for CAPVAXIVE®

  November 6, 2025

   · 

  5 min read
• Press Releases

  Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease

  November 6, 2025

   · 

  5 min read
• Press Releases

  Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia

  November 6, 2025

   · 

  5 min read
• Press Releases

  Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors

  November 6, 2025

   · 

  12 min read
• Press Releases

  NanoViricides Annual Shareholders Meeting to be Held at 10 am on Saturday, November 5th at on Saturday, November 8, 2025, at the Hampton Inn & Suites Stamford, CT

  November 6, 2025

   · 

  10 min read
• Press Releases

  Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting

  November 6, 2025

   · 

  7 min read
• Press Releases

  Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease

  November 6, 2025

   · 

  2 min read
• Press Releases

  Verismo Therapeutics to Announce Upcoming Presentations at SITC and ASH Annual Meetings

  November 6, 2025

   · 

  5 min read
• Press Releases

  Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

  November 6, 2025

   · 

  2 min read